|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 7/00 |
| (11) | Patento numeris | 3400292 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17700386.0 |
| Europos patento paraiškos padavimo data | 2017-01-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2017/050039 |
| Data | 2017-01-09 |
| (87) | Numeris | WO 2017/118867 |
| Data | 2017-07-13 |
| (30) | Numeris | Data | Šalis |
| 201600380 | 2016-01-08 | GB | |
| 201600381 | 2016-01-08 | GB | |
| 201600382 | 2016-01-08 | GB |
| (72) |
COFFIN, Robert, GB
|
| (73) |
Replimune Limited,
69 Innovation Drive Milton Park, Abingdon, Oxfordshire OX14 4RQ,
GB
|
| (54) | USE OF AN ONCOLYTIC VIRUS FOR THE TREATMENT OF CANCER |
| USE OF AN ONCOLYTIC VIRUS FOR THE TREATMENT OF CANCER |